Newsroom

Sorted by: Latest

-

KBRA Releases Research – 2025 European Securitisation: Expanding Volumes, Expanding Reach

NEW YORK--(BUSINESS WIRE)--KBRA releases research examining European securitisation market activity and the funding strategies observed in 2025. European securitisation issuance totalled approximately EUR308.9 billion in full-year 2025, reflecting a strong period of market activity and a continued normalisation of funding strategies. New issuance sold to investors (newly circulated) reached EUR168.1 billion, accounting for more than one-half of total volumes and marking one of the strongest yea...
-

River Global Investors LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: River Global Investors LLP 213800HIGHFCAY9K8Z97 (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and bene...
-

River Global Investors LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: River Global Investors LLP 213800HIGHFCAY9K8Z97 (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and bene...
-

IQM Quantum Computers Appoints Jan Goetz as Sole CEO to Lead Next Phase of Global Growth

ESPOO, Finland--(BUSINESS WIRE)--IQM Quantum Computers, a global leader in full-stack superconducting quantum computers, today announced a transition from its Co-CEO structure to a single Chief Executive Officer model. Co-founder and current Co-CEO Dr Jan Goetz becomes sole CEO effective since January 1st, following a resolution passed by the IQM board. In addition, Dr Søren Hein has been appointed Chief Operating Officer and Deputy CEO. As part of the transition, Mikko Välimäki steps down from...
-

AM Best’s Germany Briefings Return to Munich and Cologne to Discuss Key Trends Impacting European Insurers and Reinsurers

LONDON--(BUSINESS WIRE)--Members of AM Best’s insurance ratings division will share their trend observations and analytical perspectives on the global reinsurance market, along with leading issues relevant to primary insurers across Europe, at a pair of market briefings taking place in Germany. The briefings are scheduled for 3 March 2026 in Munich at the Mandarin Oriental hotel, and in Cologne on 4 March 2026 at the Excelsior Hotel Ernst. Along with an up-to-date review on the state of the glo...
-

Aesyra erzielt in klinischer Studie erhebliche Verringerung von Bruxismus im Schlaf

LAUSANNE, Schweiz--(BUSINESS WIRE)--Aesyra SA ist ein Schweizer Medtech-Unternehmen, das innovative digitale Therapien gegen Störungen entwickelt, die auf Probleme im Dentalbereich im Schlaf zurückzuführen sind. Heute hat es den erfolgreichen Abschluss seiner klinischen Studie zur Auswertung von Effizienz und Sicherheit von AesyBite™ Active bekannt gegeben. Dabei handelt es sich um eine orale Anwendung, die Bruxismus im Schlaf durch Biofeedback behandeln und verhindern soll. Die klinische Unter...
-

Samenvatting: Aesyra toont belangrijke vermindering van slaapbruxisme aan in klinisch onderzoek

LAUSANNE, Zwitserland--(BUSINESS WIRE)--Aesyra SA, een Zwitsers medisch technologiebedrijf dat innovatieve digitale therapieën ontwikkelt voor tandheelkundige en slaapgerelateerde aandoeningen, heeft vandaag bekendgemaakt dat het klinisch onderzoek naar de werkzaamheid en veiligheid van AesyBite™ Active met succes is afgerond. Het gaat hier om een intelligent mondapparaat dat is ontworpen om slaapbruxisme te behandelen en te voorkomen door middel van biofeedback. Uit klinisch onderzoek is geble...
-

Aesyra Demonstrates Significant Sleep Bruxism Reduction in Clinical Study

LAUSANNE, Switzerland--(BUSINESS WIRE)--Aesyra SA, a Swiss medtech company developing innovative digital therapeutics for dental and sleep-related disorders, today announced the successful completion of its clinical investigation evaluating the efficacy and safety of AesyBite™ Active, an intelligent oral appliance designed to treat and prevent sleep bruxism through biofeedback. The clinical investigation demonstrated that AesyBite™ Active achieved a statistically significant and clinically mean...
-

Franklin Templeton regroupe ses sociétés de crédit alternatif sous la marque BSP

PARIS--(BUSINESS WIRE)--Les activités de crédit alternatif de Franklin Templeton aux États-Unis et en Europe, Benefit Street Partners et Alcentra, sont désormais regroupées sous la marque Benefit Street Partners (BSP). Cette décision marque la dernière étape de l'intégration de BSP et d'Alcentra, deux sociétés pionnières dans le domaine du crédit alternatif acquises par Franklin Templeton respectivement en 2019 et 2022, et reflète la demande croissante des investisseurs pour une plateforme de c...
-

Franklin Templeton Aligns Alternative Credit Firms Under BSP Brand

NEW YORK & LONDON--(BUSINESS WIRE)--Franklin Templeton aligns alternative credit firms under BSP brand...